{"transactions":[{"id":680555,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T21:22:21.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":11600,"price":87.3,"value":1012680.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $87.20 to $87.44, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions."}],"balance_after":111459,"source":{"system":"sec-edgar","filing":"0001250379-26-000002","document":"wk-form4_1787260939.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000125037926000002/wk-form4_1787260939.xml","form_type":"4"}},{"id":963710,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-18T23:40:08.000Z","date":"2025-12-16","kind":"grant","planned":false,"acquired":true,"shares":7819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying restricted stock units, which shares will vest in one installment on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on such date."}],"balance_after":123059,"source":{"system":"sec-edgar","filing":"0001250379-25-000005","document":"wk-form4_1766101205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000125037925000005/wk-form4_1766101205.xml","form_type":"4"}},{"id":976893,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-09T23:04:27.000Z","date":"2025-12-05","kind":"sale","planned":false,"acquired":false,"shares":16250,"price":61.03,"value":991737.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $60.90 to $61.54, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions."}],"balance_after":115240,"source":{"system":"sec-edgar","filing":"0001250379-25-000003","document":"wk-form4_1765321464.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000125037925000003/wk-form4_1765321464.xml","form_type":"4"}},{"id":1324789,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-20T23:04:45.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":16733,"price":22.99,"value":384691.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying restricted stock units, which shares will vest in one installment on the first anniversary date."}],"balance_after":131490,"source":{"system":"sec-edgar","filing":"0001628280-24-052269","document":"wk-form4_1734735879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000162828024052269/wk-form4_1734735879.xml","form_type":"4"}},{"id":1705876,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-19T20:55:01.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":14987,"price":25.41,"value":380819.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying restricted stock units, which will vest in one installment on the first anniversary of the grant date."}],"balance_after":114754,"source":{"system":"sec-edgar","filing":"0001628280-23-041967","document":"wk-form4_1703019289.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000162828023041967/wk-form4_1703019289.xml","form_type":"4"}},{"id":2056912,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-12T01:32:11.000Z","date":"2023-01-10","kind":"grant","acquired":true,"shares":4593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents options, which will vest in one installment on the first anniversary of the grant date."}],"balance_after":4593,"derivative":{"exercise_price":33.03,"exercise_date":"2024-01-10","expiration_date":"2033-01-10","underlying":"Common Stock","underlying_shares":4593},"source":{"system":"sec-edgar","filing":"0001209191-23-003077","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919123003077/doc4.xml","form_type":"4"}},{"id":2056911,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-12T01:32:11.000Z","date":"2023-01-10","kind":"grant","acquired":true,"shares":7867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":99767,"source":{"system":"sec-edgar","filing":"0001209191-23-003077","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919123003077/doc4.xml","form_type":"4"}},{"id":2106723,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-11-22T21:46:47.000Z","date":"2022-11-21","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"These Stock Options were originally exercisable for ordinary shares of of AVITA Medical, Ltd., an Australian public company and predecessor to the Issuer (\"Predecessor\"). Pursuant to a scheme of arrangement, completed on June 30, 2020, the Stock Options became exercisable for shares of Common Stock of the Issuer in the ratio of one share of Common Stock for every 100 ordinary shares of Predecessor for which the Stock Options would otherwise have been exercisable."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from A$8.20, which reflects the 100:1 consolidation ratio applied in converting ordinary shares of Predecessor (as defined below) to shares of the Issuer's Common Stock, using the exchange rate as published by the Reserve Bank of Australia in effect on the date of grant (November 30, 2018)."}],"balance_after":0,"derivative":{"exercise_price":5.99,"exercise_date":"2020-09-09","expiration_date":"2022-11-27","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-22-058404","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919122058404/doc4.xml","form_type":"4"}},{"id":2106722,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T21:46:47.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":150000,"price":7.18,"value":1077000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.05 to $7.45. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 634,602 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above."}],"balance_after":229543,"source":{"system":"sec-edgar","filing":"0001209191-22-058404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919122058404/doc4.xml","form_type":"4"}},{"id":2106721,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T21:46:47.000Z","date":"2022-11-21","kind":"exercise","acquired":true,"shares":150000,"price":5.99,"value":898500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from A$8.20, which reflects the 100:1 consolidation ratio applied in converting ordinary shares of Predecessor (as defined below) to shares of the Issuer's Common Stock, using the exchange rate as published by the Reserve Bank of Australia in effect on the date of grant (November 30, 2018)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 634,602 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above."}],"balance_after":379543,"source":{"system":"sec-edgar","filing":"0001209191-22-058404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919122058404/doc4.xml","form_type":"4"}},{"id":2165307,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-09-06T20:15:11.000Z","date":"2022-09-01","kind":"grant","acquired":true,"shares":3450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These Stock Options were originally granted on December 22, 2021 and vested on September 1, 2022 in connection with the satisfaction of a performance-based vesting condition."}],"balance_after":6900,"derivative":{"exercise_price":12.18,"exercise_date":"2022-09-01","expiration_date":"2031-12-22","underlying":"Common Stock","underlying_shares":3450},"source":{"system":"sec-edgar","filing":"0001209191-22-048725","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919122048725/doc4.xml","form_type":"4"}},{"id":2165306,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-06T20:15:11.000Z","date":"2022-09-01","kind":"grant","acquired":true,"shares":2980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of Common Stock were issued upon the vesting of Restricted Stock Units (\"RSUs\"), which were originally granted on December 22, 2021, in connection with the satisfaction of a performance-based vesting condition."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares of Common Stock represent half of the shares of Common Stock that were issued upon the vesting of the RSUs. The other shares were transferred to the Reporting Person's former spouse pursuant to a property settlement agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 71,440 unvested RSUs with vesting conditions based on the Reporting Person's continued employment or the market price of the Issuer's common stock. Pursuant to a property settlement agreement, half of the shares of Common Stock underlying such RSUs will be transferred to the Reporting Person's former spouse upon the respective vesting events."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 634,602 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above."}],"balance_after":300983,"source":{"system":"sec-edgar","filing":"0001209191-22-048725","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919122048725/doc4.xml","form_type":"4"}},{"id":2247276,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-02T21:01:12.000Z","date":"2022-06-01","kind":"other","acquired":false,"shares":23754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of Common Stock represent half of the shares of Common Stock that were issued upon the vesting of Restricted Stock Units (\"RSUs\") that were previously included in the amount of shares of Common Stock beneficially owned by the Reporting Person. Upon vesting of the RSUs, these shares of Common Stock were transferred to the Reporting Person's former spouse pursuant to a property settlement agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 71,440 unvested RSUs with vesting conditions based on the Reporting Person's continued employment or the market price of the Issuer's common stock. Pursuant to a property settlement agreement, half of the shares of Common Stock underlying such RSUs will be transferred to the Reporting Person's former spouse upon the respective vesting events."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 634,602 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above."}],"balance_after":297958,"source":{"system":"sec-edgar","filing":"0001209191-22-033585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919122033585/doc4.xml","form_type":"4"}},{"id":2371689,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-02-25T21:54:23.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":3450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"These Stock Options were originally granted on December 22, 2021 and vested on February 23, 2022 in connection with the satisfaction of a performance-based vesting condition."}],"balance_after":3450,"derivative":{"exercise_price":12.18,"exercise_date":"2022-02-23","expiration_date":"2031-12-22","underlying":"Common Stock","underlying_shares":3450},"source":{"system":"sec-edgar","filing":"0001209191-22-013222","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919122013222/doc4.xml","form_type":"4"}},{"id":2371688,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-25T21:54:23.000Z","date":"2022-02-24","kind":"sale","acquired":false,"shares":10812,"price":8.74,"value":94496.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents shares sold in order to pay withholding taxes due in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.42 to $8.96. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs with vesting conditions based on the Reporting Person's continued employment or the market price of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 634,602 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above."}],"balance_after":321712,"source":{"system":"sec-edgar","filing":"0001209191-22-013222","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919122013222/doc4.xml","form_type":"4"}},{"id":2371687,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-25T21:54:23.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":5960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These shares of Common Stock were issued upon the vesting of RSUs, which were originally granted on December 22, 2021, in connection with the satisfaction of a performance-based vesting condition."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs with vesting conditions based on the Reporting Person's continued employment or the market price of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 634,602 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above."}],"balance_after":332524,"source":{"system":"sec-edgar","filing":"0001209191-22-013222","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919122013222/doc4.xml","form_type":"4"}},{"id":2371686,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-25T21:54:23.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":23753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of Common Stock were issued upon the vesting of Restricted Stock Units (\"RSUs\"), which were originally granted on November 26, 2019, in connection with the satisfaction of a performance-based vesting condition."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs with vesting conditions based on the Reporting Person's continued employment or the market price of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 634,602 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above."}],"balance_after":326564,"source":{"system":"sec-edgar","filing":"0001209191-22-013222","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919122013222/doc4.xml","form_type":"4"}},{"id":2440704,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-08T01:12:42.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":6400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":91900,"source":{"system":"sec-edgar","filing":"0001209191-22-002595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919122002595/doc4.xml","form_type":"4"}},{"id":2451956,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T02:30:07.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":272,"price":66.25,"value":18020.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units. The shares were sold pursuant\nto a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":85500,"source":{"system":"sec-edgar","filing":"0001209191-22-001318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919122001318/doc4.xml","form_type":"4"}},{"id":2451955,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T02:30:07.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":1600,"price":65.12,"value":104192.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units. The shares were sold pursuant\nto a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.79 to\n$65.56, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead\nPharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares\nsold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":85772,"source":{"system":"sec-edgar","filing":"0001209191-22-001318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919122001318/doc4.xml","form_type":"4"}},{"id":2451954,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T02:30:07.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":2628,"price":64.3,"value":168980.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units. The shares were sold pursuant\nto a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.77 to\n$64.77, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead\nPharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares\nsold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":87372,"source":{"system":"sec-edgar","filing":"0001209191-22-001318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919122001318/doc4.xml","form_type":"4"}},{"id":2458456,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-12-27T21:30:58.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":13800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The vesting of these Stock Options is conditioned on the market capitalizaton of the Issuer being $1.25 billion or greater for 30 consecutive calendar days on or before December 31, 2024. Upon the condition being met, a portion of the Stock Options will vest immediately and the remainder will vest in a number of annual installments depending on the year in which the condition is met."}],"balance_after":13800,"derivative":{"exercise_price":12.18,"expiration_date":"2031-12-22","underlying":"Common Stock","underlying_shares":13800},"source":{"system":"sec-edgar","filing":"0001209191-21-071256","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919121071256/doc4.xml","form_type":"4"}},{"id":2458455,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-12-27T21:30:58.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":13800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These vesting of these Stock Options is conditioned on on the market price of the Issuer's Common Stock reaching $24.36 (based upon a 10-day volume-weighted average price) by June 30, 2023. Upon the condition being met, a portion of the Stock Options will vest immediately and the remainder will vest in a number of annual installments depending on the year in which the condition is met."}],"balance_after":13800,"derivative":{"exercise_price":12.18,"expiration_date":"2031-12-22","underlying":"Common Stock","underlying_shares":13800},"source":{"system":"sec-edgar","filing":"0001209191-21-071256","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919121071256/doc4.xml","form_type":"4"}},{"id":2458454,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-12-27T21:30:58.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":13800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These Stock Options vest in four equal annual installments on December 14, 2022, 2023, 2024 and 2025."}],"balance_after":13800,"derivative":{"exercise_price":12.18,"expiration_date":"2031-12-22","underlying":"Common Stock","underlying_shares":13800},"source":{"system":"sec-edgar","filing":"0001209191-21-071256","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919121071256/doc4.xml","form_type":"4"}},{"id":2458453,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-27T21:30:58.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":23820,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents an award of RSUs with vesting conditioned on the market capitalizaton of the Issuer being $1.25 billion or greater for 30 consecutive calendar days on or before December 31, 2024. Upon the condition being met, a portion of the RSUs will vest immediately and the remainder will vest in a number of annual installments depending on the year in which the condition is met."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 634,602 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above."}],"balance_after":302811,"source":{"system":"sec-edgar","filing":"0001209191-21-071256","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919121071256/doc4.xml","form_type":"4"}},{"id":2458452,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-27T21:30:58.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":23820,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents an award of RSUs with vesting conditioned on the market price of the Issuer's Common Stock reaching $24.36 (based upon a 10-day volume-weighted average price) by June 30, 2023. Upon the condition being met, a portion of the RSUs will vest immediately and the remainder will vest in a number of annual installments depending on the year in which the condition is met."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 634,602 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above."}],"balance_after":278991,"source":{"system":"sec-edgar","filing":"0001209191-21-071256","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919121071256/doc4.xml","form_type":"4"}},{"id":2458451,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-27T21:30:58.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":23800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest in four equal annual installments on December 14, 2022, 2023, 2024 and 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 634,602 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Amount in column 5 reflects a decrease of 6,267 shares of Common Stock from the total reported in the Reporting Person's Form 4 filed on September 7, 2021 (the \"Prior Form 4\") following the finalization of a division of property with the Reporting Person's former spouse pursuant to a property settlement agreement.  The Reporting Person no longer reports as beneficially owned any securities owned by his former spouse following a separation occurring after the Prior Form 4."}],"balance_after":255171,"source":{"system":"sec-edgar","filing":"0001209191-21-071256","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919121071256/doc4.xml","form_type":"4"}},{"id":2577065,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-07T20:05:26.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":11220,"price":20.68,"value":232029.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares sold in order to pay withholding taxes due in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.36 to $20.82. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 634,602 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 47,507 unvested RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs were originally rights to receive ordinary shares of AVITA Medical, Ltd., an Australian public company and predecessor to the Issuer (\"Predecessor\"). Pursuant to a scheme of arrangement, completed on June 30, 2020, such RSUs became rights to be issued shares of Common Stock of the Issuer in the ratio of one share of Common Stock for every 100 ordinary shares of Predecessor to which the holder would otherwise have been entitled. The RSUs vest on June 1, 2022."}],"balance_after":237638,"source":{"system":"sec-edgar","filing":"0001209191-21-054958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919121054958/doc4.xml","form_type":"4"}},{"id":2577064,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-07T20:05:26.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":23754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of Common Stock were issued in connection with the vesting of Restricted Stock Units (\"RSUs\"), which were originally granted on November 26, 2019, upon the satisfaction of a performance-based vesting condition."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 634,602 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 47,507 unvested RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs were originally rights to receive ordinary shares of AVITA Medical, Ltd., an Australian public company and predecessor to the Issuer (\"Predecessor\"). Pursuant to a scheme of arrangement, completed on June 30, 2020, such RSUs became rights to be issued shares of Common Stock of the Issuer in the ratio of one share of Common Stock for every 100 ordinary shares of Predecessor to which the holder would otherwise have been entitled. The RSUs vest on June 1, 2022."}],"balance_after":248858,"source":{"system":"sec-edgar","filing":"0001209191-21-054958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919121054958/doc4.xml","form_type":"4"}},{"id":2680632,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-04T20:06:08.000Z","date":"2021-06-02","kind":"sale","acquired":false,"shares":23000,"price":17.33,"value":398590.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold in order to pay withholding taxes due in connection with the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.11 to $17.73. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 634,602 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 47,507 unvested RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs were originally rights to receive ordinary shares of AVITA Medical, Ltd., an Australian public company and predecessor to the Issuer (\"Predecessor\"). Pursuant to a scheme of arrangement, completed on June 30, 2020, the RSUs became rights to be issued shares of Common Stock of the Issuer in the ratio of one share of Common Stock for every 100 ordinary shares of Predecessor to which the holder would otherwise have been entitled. The RSUs vest on June 1, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"631,525 CDIs, which translate into 126,305 shares of Common Stock, and 50,677 shares of Common Stock were previously transferred to the Reporting Person's former spouse pursuant to a property settlement agreement entered into in connection with a divorce proceeding. The Reporting Person no longer reports as beneficially owned any securities owned by his former spouse."}],"balance_after":225104,"source":{"system":"sec-edgar","filing":"0001209191-21-038189","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919121038189/doc4.xml","form_type":"4"}},{"id":2923324,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Sold","published_at":"2021-01-05T23:14:01.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":4000,"price":76.09,"value":304360.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.06 to $76.33, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":90000,"source":{"system":"sec-edgar","filing":"0001209191-21-001538","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919121001538/doc4.xml","form_type":"4"}},{"id":2923323,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T23:14:01.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":94000,"source":{"system":"sec-edgar","filing":"0001209191-21-001538","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919121001538/doc4.xml","form_type":"4"}},{"id":3029877,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-09-16T23:15:06.000Z","date":"2020-09-16","kind":"sale","acquired":false,"shares":9000,"price":27.41,"value":246690.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares sold in order to pay withholding taxes due in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.30 to $28.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,266,125 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 1,266,125 CDIs, which translate into 253,225 of the shares of Common Stock set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 95,014 unvested RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs were originally rights to receive ordinary shares of AVITA Medical, Ltd., an Australian public company and predecessor to the Issuer (\"Predecessor\"). Pursuant to a scheme of arrangement, completed on June 30, 2020, the RSUs became rights to be issued shares of Common Stock of the Issuer in the ratio of one share of Common Stock for every 100 ordinary shares of Predecessor to which the holder would otherwise have been entitled. The RSUs vest in two equal installments on June 1, 2021 and 2022."}],"balance_after":425087,"source":{"system":"sec-edgar","filing":"0001209191-20-050769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919120050769/doc4.xml","form_type":"4"}},{"id":3029876,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-09-16T23:15:06.000Z","date":"2020-09-15","kind":"sale","acquired":false,"shares":23769,"price":27.23,"value":647229.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares sold in order to pay withholding taxes due in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.11 to $27.64. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,266,125 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 1,266,125 CDIs, which translate into 253,225 of the shares of Common Stock set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 95,014 unvested RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs were originally rights to receive ordinary shares of AVITA Medical, Ltd., an Australian public company and predecessor to the Issuer (\"Predecessor\"). Pursuant to a scheme of arrangement, completed on June 30, 2020, the RSUs became rights to be issued shares of Common Stock of the Issuer in the ratio of one share of Common Stock for every 100 ordinary shares of Predecessor to which the holder would otherwise have been entitled. The RSUs vest in two equal installments on June 1, 2021 and 2022."}],"balance_after":434087,"source":{"system":"sec-edgar","filing":"0001209191-20-050769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919120050769/doc4.xml","form_type":"4"}},{"id":3029875,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-09-16T23:15:06.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":15092,"price":26.99,"value":407333.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares sold in order to pay withholding taxes due in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.40 to $27.07. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,266,125 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 1,266,125 CDIs, which translate into 253,225 of the shares of Common Stock set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 95,014 unvested RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs were originally rights to receive ordinary shares of AVITA Medical, Ltd., an Australian public company and predecessor to the Issuer (\"Predecessor\"). Pursuant to a scheme of arrangement, completed on June 30, 2020, the RSUs became rights to be issued shares of Common Stock of the Issuer in the ratio of one share of Common Stock for every 100 ordinary shares of Predecessor to which the holder would otherwise have been entitled. The RSUs vest in two equal installments on June 1, 2021 and 2022."}],"balance_after":457856,"source":{"system":"sec-edgar","filing":"0001209191-20-050769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919120050769/doc4.xml","form_type":"4"}},{"id":3029874,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-09-16T23:15:06.000Z","date":"2020-09-14","kind":"grant","acquired":true,"shares":68504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These shares of Common Stock were issued in connection with the vesting of Restricted Stock Units (\"RSUs\"), which were originally granted on November 26, 2019, upon the satisfaction of a performance-based vesting condition."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,266,125 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 1,266,125 CDIs, which translate into 253,225 of the shares of Common Stock set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 95,014 unvested RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs were originally rights to receive ordinary shares of AVITA Medical, Ltd., an Australian public company and predecessor to the Issuer (\"Predecessor\"). Pursuant to a scheme of arrangement, completed on June 30, 2020, the RSUs became rights to be issued shares of Common Stock of the Issuer in the ratio of one share of Common Stock for every 100 ordinary shares of Predecessor to which the holder would otherwise have been entitled. The RSUs vest in two equal installments on June 1, 2021 and 2022."}],"balance_after":472948,"source":{"system":"sec-edgar","filing":"0001209191-20-050769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919120050769/doc4.xml","form_type":"4"}},{"id":3033064,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-09-11T23:59:07.000Z","date":"2020-09-09","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"These Stock Options were originally exercisable for ordinary shares of Predecessor. Pursuant to the Scheme, the Stock Options became exercisable for shares of Common Stock of the Issuer in the ratio of one share of Common Stock for every 100 ordinary shares of Predecessor for which the Stock Options would otherwise have been exercisable."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The exercise price was converted from A$8.20, which reflects the 100:1 consolidation ratio applied in converting ordinary shares of Predecessor\nto shares of the Issuer's Common Stock, using the exchange rate as published by the Reserve Bank of Australia in effect on the date of grant\n(November 30, 2018). The actual exercise price will be the Australian dollar amount regardless of the exchange rate on the date of grant or of\nexercise."},{"field":"date","element":"transactionDate","label":"F9","text":"On November 30, 2018, the Reporting Person was granted Stock Options to purchase 150,000 shares of Common Stock, vesting based on the satisfaction of certain time-based and performance-based conditions. On September 9, 2020, the performance-based vesting condition with respect to the last 25,000 unvested Stock Options was satisfied."}],"balance_after":150000,"derivative":{"exercise_price":5.99,"exercise_date":"2020-09-09","expiration_date":"2028-11-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-050215","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919120050215/doc4.xml","form_type":"4"}},{"id":3033063,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-09-11T23:59:07.000Z","date":"2020-09-11","kind":"sale","acquired":false,"shares":20000,"price":26.02,"value":520400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares sold in order to pay withholding taxes due in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.77 to $26.26. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":404444,"source":{"system":"sec-edgar","filing":"0001209191-20-050215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919120050215/doc4.xml","form_type":"4"}},{"id":3033062,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-09-11T23:59:07.000Z","date":"2020-09-10","kind":"sale","acquired":false,"shares":7128,"price":26.26,"value":187181.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares sold in order to pay withholding taxes due in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.53. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":424444,"source":{"system":"sec-edgar","filing":"0001209191-20-050215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919120050215/doc4.xml","form_type":"4"}},{"id":3033061,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-09-11T23:59:07.000Z","date":"2020-09-09","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These shares of Common Stock were issued in connection with the vesting of Restricted Stock Units (\"RSUs\"), which were originally granted on November 30, 2018, upon the satisfaction of a performance-based vesting condition."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,266,125 of the Issuer's CHESS Depositary Interests (\"CDIs\"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the \"ASX\") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 1,266,125 CDIs, which translate into 253,225 of the shares of Common Stock set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 95,014 unvested RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs were originally rights to receive ordinary shares of AVITA Medical, Ltd., an Australian public company and predecessor to the Issuer (\"Predecessor\"). Pursuant to a scheme of arrangement, completed on June 30, 2020 (the \"Scheme\"), the RSUs became rights to be issued shares of Common Stock of the Issuer in the ratio of one share of Common Stock for every 100 ordinary shares of Predecessor to which the holder would otherwise have been entitled. The RSUs vest in two equal installments on June 1, 2021 and 2022."}],"balance_after":431572,"source":{"system":"sec-edgar","filing":"0001209191-20-050215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250379/000120919120050215/doc4.xml","form_type":"4"}},{"id":3146272,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (right to buy)","published_at":"2020-05-18T22:27:18.000Z","date":"2020-05-14","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents first vesting date. Option vested over four years from date of grant."}],"balance_after":0,"derivative":{"exercise_price":4.2,"exercise_date":"2012-01-01","expiration_date":"2021-12-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-030214","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/doc4.xml","form_type":"4"}},{"id":3146271,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (right to buy)","published_at":"2020-05-18T22:27:18.000Z","date":"2020-05-14","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vested entirely on the one year anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":5.19,"exercise_date":"2013-02-16","expiration_date":"2022-02-16","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-030214","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/doc4.xml","form_type":"4"}},{"id":3146270,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (right to buy)","published_at":"2020-05-18T22:27:18.000Z","date":"2020-05-14","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vested entirely on the one year anniversary of the grant date."}],"balance_after":40000,"derivative":{"exercise_price":2.62,"exercise_date":"2013-09-28","expiration_date":"2022-09-28","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-030214","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/doc4.xml","form_type":"4"}},{"id":3146269,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (right to buy)","published_at":"2020-05-18T22:27:18.000Z","date":"2020-05-14","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vested entirely on the one year anniversary of the grant date."}],"balance_after":50000,"derivative":{"exercise_price":2.19,"exercise_date":"2014-03-21","expiration_date":"2023-03-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-030214","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/doc4.xml","form_type":"4"}},{"id":3146268,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (right to buy)","published_at":"2020-05-18T22:27:18.000Z","date":"2020-05-14","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vested entirely on the one year anniversary of the grant date."}],"balance_after":65000,"derivative":{"exercise_price":2.01,"exercise_date":"2014-05-06","expiration_date":"2023-05-06","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-20-030214","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/doc4.xml","form_type":"4"}},{"id":3146267,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (right to buy)","published_at":"2020-05-18T22:27:18.000Z","date":"2020-05-14","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vested entirely on the one year anniversary of the grant date."}],"balance_after":70000,"derivative":{"exercise_price":4.75,"exercise_date":"2014-09-21","expiration_date":"2023-09-21","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-20-030214","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/doc4.xml","form_type":"4"}},{"id":3146266,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-18T22:27:18.000Z","date":"2020-05-14","kind":"exercise","acquired":true,"shares":25000,"price":4.2,"value":105000.0,"ownership":{"direct":true},"balance_after":85000,"source":{"system":"sec-edgar","filing":"0001209191-20-030214","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/doc4.xml","form_type":"4"}},{"id":3146265,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-18T22:27:18.000Z","date":"2020-05-14","kind":"exercise","acquired":true,"shares":15000,"price":5.19,"value":77850.0,"ownership":{"direct":true},"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001209191-20-030214","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/doc4.xml","form_type":"4"}},{"id":3146264,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-18T22:27:18.000Z","date":"2020-05-14","kind":"exercise","acquired":true,"shares":10000,"price":2.62,"value":26200.0,"ownership":{"direct":true},"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001209191-20-030214","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/doc4.xml","form_type":"4"}},{"id":3146263,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-18T22:27:18.000Z","date":"2020-05-14","kind":"exercise","acquired":true,"shares":15000,"price":2.19,"value":32850.0,"ownership":{"direct":true},"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001209191-20-030214","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/doc4.xml","form_type":"4"}},{"id":3146262,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-18T22:27:18.000Z","date":"2020-05-14","kind":"exercise","acquired":true,"shares":5000,"price":2.01,"value":10050.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-20-030214","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/doc4.xml","form_type":"4"}},{"id":3146261,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-18T22:27:18.000Z","date":"2020-05-14","kind":"exercise","acquired":true,"shares":7000,"price":4.75,"value":33250.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-20-030214","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120030214/doc4.xml","form_type":"4"}},{"id":3151609,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-13T22:48:31.000Z","date":"2020-05-12","kind":"sale","acquired":false,"shares":6100,"price":36.42,"value":222162.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-20-028978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120028978/doc4.xml","form_type":"4"}},{"id":3151608,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-13T22:48:31.000Z","date":"2020-05-12","kind":"sale","acquired":false,"shares":29900,"price":35.71,"value":1067729.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.35 to\n$36.35, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead\nPharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares\nsold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":14100,"source":{"system":"sec-edgar","filing":"0001209191-20-028978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120028978/doc4.xml","form_type":"4"}},{"id":3271840,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2020-02-14T22:58:19.000Z","date":"2019-05-09","kind":"other","acquired":false,"shares":46666,"price":12065.46,"value":563046756.36,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Price reported is reflective of adjustments made to the exercise price after the date of issuance pursuant to the terms of the warrant."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported securities were redeemed by the issuer for $12,065.46."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The number of shares of common stock for which the warrant was exercisable does not reflect the 1-for-14 reverse stock split that was effected on May 9, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The warrant was held by One Funds Management Limited as Trustee for Asia Pacific Healthcare Fund II (\"One Funds Management\"). The Reporting Person may be deemed to have shared voting and dispositive power over the shares beneficially owned by One Funds Management but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":0.3223,"exercise_date":"2016-11-22","expiration_date":"2021-11-22","underlying":"Common Stock","underlying_shares":46666},"source":{"system":"sec-edgar","filing":"0001104659-20-022091","document":"tm208184-6_form5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465920022091/tm208184-6_form5.xml","form_type":"5"}},{"id":3324910,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T23:08:35.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":44000,"source":{"system":"sec-edgar","filing":"0001209191-20-001366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120001366/doc4.xml","form_type":"4"}},{"id":3417982,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-12T00:09:04.000Z","date":"2019-09-11","kind":"sale","acquired":false,"shares":85000,"price":30,"value":2550000.0,"ownership":{"direct":true},"balance_after":36000,"source":{"system":"sec-edgar","filing":"0001209191-19-049237","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119049237/doc4.xml","form_type":"4"}},{"id":3417981,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-12T00:09:04.000Z","date":"2019-09-09","kind":"sale","acquired":false,"shares":100000,"price":28.9,"value":2890000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.88 to $28.95, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":121000,"source":{"system":"sec-edgar","filing":"0001209191-19-049237","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119049237/doc4.xml","form_type":"4"}},{"id":3512529,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-25T01:30:29.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":27383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each annual anniversary of the date of grant."}],"balance_after":27383,"derivative":{"exercise_price":3.15,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":27383},"source":{"system":"sec-edgar","filing":"0001144204-19-028256","document":"tv522362_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000114420419028256/tv522362_4.xml","form_type":"4"}},{"id":3710966,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T01:15:22.000Z","date":"2019-01-01","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":221000,"source":{"system":"sec-edgar","filing":"0001209191-19-001543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919119001543/doc4.xml","form_type":"4"}},{"id":3983400,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-27T00:51:25.000Z","date":"2018-03-22","kind":"purchase","acquired":true,"shares":181820,"price":1.1,"value":200002.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by One Funds Management. The Reporting Person may be deemed to have shared voting and dispositive power over the shares beneficially owned by One Funds Management but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein, if any."}],"balance_after":411105,"source":{"system":"sec-edgar","filing":"0001209191-18-021679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/921114/000120919118021679/doc4.xml","form_type":"4"}},{"id":3983399,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-27T00:51:25.000Z","date":"2017-09-19","kind":"purchase","acquired":true,"shares":105015,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Shares were issued pursuant to a Common Stock Issuance Agreement, dated April 8, 2016, between the Issuer and certain holders of the Issuer's Series B Preferred Stock (the \"Holders\"), as amended. As consideration for the Shares, among other things, the Holders waived their right to receive certain cash payments to which they were entitled upon the conversion of their Series B Preferred Stock and also waived certain registration rights relating to certain future registration statements or public offerings that may be filed or conducted by the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by One Funds Management. The Reporting Person may be deemed to have shared voting and dispositive power over the shares beneficially owned by One Funds Management but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein, if any."}],"balance_after":229285,"source":{"system":"sec-edgar","filing":"0001209191-18-021679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921114/000120919118021679/doc4.xml","form_type":"4"}},{"id":3983398,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-27T00:51:25.000Z","date":"2017-06-29","kind":"purchase","acquired":true,"shares":5757,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Shares were issued pursuant to a Common Stock Issuance Agreement, dated April 8, 2016, between the Issuer and certain holders of the Issuer's Series B Preferred Stock (the \"Holders\"), as amended. As consideration for the Shares, among other things, the Holders waived their right to receive certain cash payments to which they were entitled upon the conversion of their Series B Preferred Stock and also waived certain registration rights relating to certain future registration statements or public offerings that may be filed or conducted by the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person acquired beneficial ownership of these shares upon his appointment as a Managing Director of Bioscience Managers Pty Ltd. in April 2017. Bioscience Managers Pty Ltd. is an affiliate of One Funds Management Limited as Trustee for Asia Pacific Healthcare Fund II (\"One Funds Management\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by One Funds Management. The Reporting Person may be deemed to have shared voting and dispositive power over the shares beneficially owned by One Funds Management but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein, if any."}],"balance_after":124270,"source":{"system":"sec-edgar","filing":"0001209191-18-021679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000120919118021679/doc4.xml","form_type":"4"}},{"id":4114703,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T00:42:56.000Z","date":"2018-01-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":185000,"source":{"system":"sec-edgar","filing":"0001209191-18-001536","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919118001536/doc4.xml","form_type":"4"}},{"id":4212053,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-12T21:56:10.000Z","date":"2017-09-07","kind":"grant","acquired":true,"shares":10900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10900,"derivative":{"exercise_price":0.91,"exercise_date":"2018-09-07","expiration_date":"2027-09-06","underlying":"Common Stock","underlying_shares":10900},"source":{"system":"sec-edgar","filing":"0001209191-17-052468","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000120919117052468/doc4.xml","form_type":"4"}},{"id":4505001,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":21398,"kind":"person","name":"PERRY MICHAEL S","position":1,"cik":"0001250379","reported_name":"PERRY MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-05T01:52:40.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":155000,"source":{"system":"sec-edgar","filing":"0001209191-17-001622","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919117001622/doc4.xml","form_type":"4"}}]}